Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia

Pediatr Int. 2010 Feb;52(1):137-41. doi: 10.1111/j.1442-200X.2009.02947.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Candida tropicalis*
  • Candidiasis / drug therapy*
  • Drug Therapy, Combination
  • Echinocandins / administration & dosage*
  • Echinocandins / adverse effects
  • Follow-Up Studies
  • Fungemia / drug therapy*
  • Humans
  • Infant
  • Lipopeptides / administration & dosage*
  • Lipopeptides / adverse effects
  • Male
  • Micafungin
  • Opportunistic Infections / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Pulmonary Aspergillosis / drug therapy*
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects
  • Tomography, X-Ray Computed
  • Triazoles / administration & dosage*
  • Triazoles / adverse effects
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Pyrimidines
  • Triazoles
  • Voriconazole
  • Micafungin